XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development $ 7,899 $ 4,073
General and administrative 3,054 4,341
Total operating expenses 10,953 8,414
Loss from operations (10,953) (8,414)
Other expense, net 667 280
Net loss and comprehensive loss $ (11,620) $ (8,694)
Net loss per share, basic and diluted $ (0.13) $ (0.22)
Weighted average number of shares of common stock used in computing net loss per share, basic and diluted 86,651,036 40,180,131